(+)-2-[1-(3-Ethoxy-4-Methoxyphenyl)-2-Methylsulfonylethyl]-4-Acetylaminoisoindoline-1,3-Dione:, and Methods of Synthesis and Compositions Thereof
A patent family: one line of work, grouped by real continuity rather than by a technology label
inferred from titles. 3 of these applications claim priority to application 61/601,226, filed Feb 21, 2012. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
| Patent | Title | Holder | Status | Expires | Time remaining | Confidence |
|---|---|---|---|---|---|---|
| US 7,662,847 | Methods of Using N-Alkyl-Hydroxamic Acid-Isoindolyl Compounds In force · High confidence | Amgen Inc. | In force | High confidence | ||
| US 7,427,638 | (+)-2-[1-(3-Ethoxy-4-Methoxyphenyl)-2-Methylsulfonylethyl]-4-Acetylaminoisoindoline-1,3-Dione:, and Methods of Synthesis and Compositions Thereof In force · High confidence | Amgen Inc. | In force | High confidence | ||
| US D735,315 | Pharmaceutical Tablet In force · High confidence | Amgen Inc. | In force | High confidence | ||
| US 9,616,019 | Nanosuspension of a Poorly Soluble Drug via Microfluidization Process In force · High confidence | Amgen Inc. | In force | High confidence | ||
| US 9,023,886 | Nanosuspension of a Poorly Soluble Drug via Microfluidization Process In force · High confidence | Amgen Inc. | In force | High confidence | ||
| US 9,532,977 | Controlled Release Oral Dosage Forms of Poorly Soluble Drugs and Uses Thereof In force · High confidence | Amgen Inc. | In force | High confidence | ||
| US 9,045,417 | Isotopologues of Isoindole Derivatives In force · High confidence | Amgen Inc. | In force | High confidence | ||
| US 9,642,836 | Isotopologues of Isoindole Derivatives In force · High confidence | Amgen Inc. | In force | High confidence | ||
| US 8,853,175 | Phenethylsulfone Isoindoline Derivatives and Their Use In force · High confidence | Amgen Inc. | In force | High confidence | ||
| US 9,387,195 | Methods for Treating Diseases Using Isoindoline Compounds In force · High confidence | Amgen Inc. | In force | High confidence | ||
| 52 more patents in this group · Pro | ||||||
10 of 62 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
Pro members see all 62, including 32 expired and 2 expiring within the 18 months from Nov 16, 2026.
26 of these are in force and held by Amgen Inc..
Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.